SCHOTT Pharma KGaA Balance Sheet Health
Financial Health criteria checks 5/6
SCHOTT Pharma KGaA has a total shareholder equity of €721.2M and total debt of €112.8M, which brings its debt-to-equity ratio to 15.6%. Its total assets and total liabilities are €1.2B and €520.2M respectively. SCHOTT Pharma KGaA's EBIT is €179.0M making its interest coverage ratio 70.2. It has cash and short-term investments of €21.3M.
Key information
15.6%
Debt to equity ratio
€112.84m
Debt
| Interest coverage ratio | 70.2x |
| Cash | €21.34m |
| Equity | €721.18m |
| Total liabilities | €520.18m |
| Total assets | €1.24b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 1SXP's short term assets (€465.2M) exceed its short term liabilities (€298.5M).
Long Term Liabilities: 1SXP's short term assets (€465.2M) exceed its long term liabilities (€221.7M).
Debt to Equity History and Analysis
Debt Level: 1SXP's net debt to equity ratio (12.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 1SXP's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 1SXP's debt is well covered by operating cash flow (194.9%).
Interest Coverage: 1SXP's interest payments on its debt are well covered by EBIT (70.2x coverage).